Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vivos Therapeutics Inc (VVOS)

Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,608
  • Shares Outstanding, K 10,468
  • Annual Sales, $ 15,030 K
  • Annual Income, $ -11,140 K
  • EBIT $ -15 M
  • EBITDA $ -15 M
  • 60-Month Beta 6.92
  • Price/Sales 0.67
  • Price/Cash Flow N/A
  • Price/Book 3.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.45
  • Number of Estimates 1
  • High Estimate $-0.45
  • Low Estimate $-0.45
  • Prior Year $-0.45
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0850 +22.92%
on 03/30/26
1.5000 -11.09%
on 03/11/26
-0.0763 (-5.41%)
since 03/02/26
3-Month
1.0850 +22.92%
on 03/30/26
2.6900 -50.42%
on 01/05/26
-1.1963 (-47.28%)
since 01/02/26
52-Week
1.0850 +22.92%
on 03/30/26
7.9500 -83.22%
on 07/11/25
-1.2363 (-48.11%)
since 04/02/25

Most Recent Stories

More News
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)

The show also broadcasts across MENA and Latin America as sponsored programming.

TRN : 32.88 (-0.42%)
PETV : 0.7425 (+6.07%)
SNYR : 0.8859 (-13.15%)
ACXP : 3.51 (-9.77%)
IGC : 0.2680 (-1.25%)
VTIX : 6.16 (-3.45%)
LTRN : 1.6450 (+15.85%)
NRXP : 2.19 (+1.39%)
YYGH : 1.0500 (-1.87%)
DVLT : 0.6500 (-4.19%)
VVOS : 1.3250 (+1.92%)
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market

Insurance Coverage on Vivos Appliances and Treatment Now Available to a Significant Number of Nevada Patients Previously Unable to Access Coverage Concurrently, Vivos Implements Cost Reduction Initiatives...

VVOS : 1.3250 (+1.92%)
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy

LITTLETON, Colo., March 17, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS),  a leading medical device and healthcare services company focused...

VVOS : 1.3250 (+1.92%)
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM EST

The Show Will Also Air Across Latin America and MENA 1230 pm local time.

VTIX : 6.16 (-3.45%)
MDCX : 0.4300 (+2.38%)
CITR : 8.30 (-0.72%)
VVOS : 1.3250 (+1.92%)
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America

Commercial Sponsors

SNYR : 0.8859 (-13.15%)
PETV : 0.7425 (+6.07%)
NTHI : 5.51 (-9.52%)
BIVI : 1.3800 (unch)
VTIX : 6.16 (-3.45%)
YYGH : 1.0500 (-1.87%)
SGTM : 0.3699 (-3.24%)
VVOS : 1.3250 (+1.92%)
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)

The show broadcasts as sponsored programming with national TV commercials from Synergy CHC (NASDAQ:SNYR), NeOnc Technologies (NASDAQ:NTHI), PetVivo (OTCQX:PETV), and YY Group Holdings (NASDAQ:YYGH).

SNYR : 0.8859 (-13.15%)
PETV : 0.7425 (+6.07%)
NTHI : 5.51 (-9.52%)
SDST : 2.61 (+1.56%)
VTIX : 6.16 (-3.45%)
AERT : 0.4623 (+14.54%)
YYGH : 1.0500 (-1.87%)
VVOS : 1.3250 (+1.92%)
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Vivos adds more cutting-edge products to its roster serving the breathing and sleep wellness market LITTLETON, Colo., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos”...

VVOS : 1.3250 (+1.92%)
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street

Twelve months of national and global coverage to include long-form interviews, earned media, television commercials, iconic outdoor billboards, and accredited investor events

VVOS : 1.3250 (+1.92%)
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

LITTLETON, Colo., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on...

VVOS : 1.3250 (+1.92%)
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

LITTLETON, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on...

VVOS : 1.3250 (+1.92%)

Business Summary

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

See More

Key Turning Points

3rd Resistance Point 1.5167
2nd Resistance Point 1.4133
1st Resistance Point 1.3567
Last Price 1.3250
1st Support Level 1.1967
2nd Support Level 1.0933
3rd Support Level 1.0367

See More

52-Week High 7.9500
Fibonacci 61.8% 5.3276
Fibonacci 50% 4.5175
Fibonacci 38.2% 3.7074
Last Price 1.3250
52-Week Low 1.0850

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.